Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Exp Neurol ; 177(2): 503-14, 2002 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-12429195

RESUMO

Activation of the superior colliculus has been shown to reproduce the antiepileptic effect of the inhibition of the substantia nigra reticulata. A circuit involving neurons of the caudal deep layers of the superior colliculus has been suggested to control brain stem convulsive seizures. The present study was designed to examine whether a similar circuit is also involved in the control of absence seizures. For this, activation of either the rostral or caudal parts of the deep and intermediate layers of the superior colliculus was applied in a genetic model of absence seizures in the rat (GAERS). Single-shock (5 s) electrical stimulation of the rostral and caudal superior colliculus interrupted ongoing spike-and-wave discharges at an intensity (antiepileptic threshold) significantly lower than the intensity inducing behavioral effects. At this intensity, no interruption of licking behavior was observed in water-deprived rats. Repeated stimulations (5 s on/5 s off) at the antiepileptic threshold reduced absence seizures only during the first 10 min. Bilateral microinjection of a GABA antagonist (picrotoxin, 33 pmol/side) significantly suppressed spike-and-wave discharges when applied in the caudal aspect of the superior colliculus. This antiepileptic effect appears dissociated from an anxiogenic effect, as tested in an elevated plus maze test. Finally, bilateral injection of picrotoxin (33 pmol/side) appeared more effective in the superficial and intermediate layers of the caudal superior colliculus, whereas such injections had only weak effects on absence seizures when applied in the deep layers. These results suggest that a specific population of neurons located in the intermediate and superficial layers of the caudal superior colliculus is involved in the inhibitory control of absence seizures. It may constitute an important relay for the control of absence seizures by the basal ganglia via the substantia nigra reticulata.


Assuntos
Modelos Animais de Doenças , Terapia por Estimulação Elétrica/métodos , Epilepsia Tipo Ausência/fisiopatologia , Epilepsia Tipo Ausência/terapia , Colículos Superiores/fisiopatologia , Animais , Ansiedade/induzido quimicamente , Comportamento Animal/efeitos dos fármacos , Eletroencefalografia/efeitos dos fármacos , Medo/efeitos dos fármacos , Antagonistas GABAérgicos/efeitos adversos , Antagonistas GABAérgicos/uso terapêutico , Antagonistas de Receptores de GABA-A , Predisposição Genética para Doença , Masculino , Aprendizagem em Labirinto/efeitos dos fármacos , Microinjeções , Inibição Neural/efeitos dos fármacos , Picrotoxina/efeitos adversos , Picrotoxina/uso terapêutico , Ratos , Ratos Endogâmicos , Resultado do Tratamento , Privação de Água
2.
Neuroscience ; 105(1): 203-11, 2001.
Artigo em Inglês | MEDLINE | ID: mdl-11483312

RESUMO

GABAergic inhibition of the substantia nigra pars reticulata has been shown to suppress seizures in most models of epilepsy involving forebrain networks, such as absences or clonic seizures. No such antiepileptic effects were observed, however, in genetically audiogenic rats exhibiting tonic seizures generated in the brainstem. This suggests a constitutive dysfunction of the nigral GABAergic neurotransmission in this strain of rat or a selective action of the nigral control on specific networks. In the present study, we first confirmed that bilateral injection of muscimol (700 pmol/side) in the substantia nigra had no effect in Wistar rats with audiogenic seizures (Wistar AS). [3H]Muscimol autoradiography suggested a 40% reduced density of GABA(A) receptors in the substantia nigra of Wistar AS, whereas no change was observed in the cortex and the superior colliculus (superficial and intermediate layers), as compared to control animals. In Wistar AS where 40 repetitions of audiogenic stimulations progressively induced generalised convulsive seizures with both tonic and clonic components, bilateral injection of muscimol (350 pmol/side) in the substantia nigra suppressed the clonic component but had no effect on tonic seizures. In hybrid rats issued from cross-breeding between Wistar AS and rats with spontaneous absence seizures, bilateral injection of muscimol (18 pmol/side) in the substantia nigra abolished cortical spike-and-wave discharges, but had no effect on tonic audiogenic seizures at doses up to 700 pmol/side. These results show that despite a decreased number of GABA(A) receptors in the substantia nigra, inhibition of this structure in Wistar AS still leads to inhibition of seizures involving forebrain structures. These results confirm that GABAergic inhibition of the substantia nigra has antiepileptic effects through the control of forebrain circuits. They suggest that this control mechanism has no inhibitory effect on circuits underlying audiogenic tonic seizures.


Assuntos
Epilepsia Tipo Ausência/fisiopatologia , Epilepsia Reflexa/fisiopatologia , Inibição Neural/fisiologia , Neurônios/metabolismo , Convulsões/fisiopatologia , Substância Negra/fisiopatologia , Ácido gama-Aminobutírico/metabolismo , Estimulação Acústica/efeitos adversos , Animais , Vias Auditivas/efeitos dos fármacos , Vias Auditivas/metabolismo , Vias Auditivas/fisiopatologia , Eletroencefalografia/efeitos dos fármacos , Epilepsia Tipo Ausência/metabolismo , Epilepsia Reflexa/genética , Epilepsia Reflexa/metabolismo , Agonistas GABAérgicos/farmacocinética , Agonistas de Receptores de GABA-A , Excitação Neurológica/efeitos dos fármacos , Excitação Neurológica/fisiologia , Masculino , Muscimol/farmacocinética , Rede Nervosa/efeitos dos fármacos , Rede Nervosa/metabolismo , Rede Nervosa/fisiopatologia , Inibição Neural/efeitos dos fármacos , Neurônios/efeitos dos fármacos , Ensaio Radioligante , Ratos , Ratos Wistar , Receptores de GABA-A/metabolismo , Convulsões/metabolismo , Substância Negra/efeitos dos fármacos , Substância Negra/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA